| 标题 |
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator (D1PAM), in Healthy Subjects |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clin Pharmacol Drug Dev 作者:Wilbraham D, Biglan KM, Svensson KA, Tsai M, Kielbasa W 出版日期:2020-10-07 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)